These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18180999)

  • 1. Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations.
    Miao N; Pingpank JF; Alexander HR; Steinberg SM; Beresneva T; Quezado ZM
    Ann Surg Oncol; 2008 Mar; 15(3):815-23. PubMed ID: 18180999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of partial venovenous cardiopulmonary bypass in percutaneous hepatic perfusion for patients with diffuse, isolated liver metastases: a case series.
    Fitzpatrick M; Richard Alexander H; Deshpande SP; Martz DG; McCormick B; Grigore AM
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):647-51. PubMed ID: 24290749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two European centers.
    Vogl TJ; Zangos S; Scholtz JE; Schmitt F; Paetzold S; Trojan J; Orsi F; Lotz G; Ferrucci P
    Rofo; 2014 Oct; 186(10):937-44. PubMed ID: 24729409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.
    Meijer TS; Burgmans MC; Fiocco M; de Geus-Oei LF; Kapiteijn E; de Leede EM; Martini CH; van der Meer RW; Tijl FGJ; Vahrmeijer AL
    Cardiovasc Intervent Radiol; 2019 Jun; 42(6):841-852. PubMed ID: 30767147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
    de Leede EM; Burgmans MC; Meijer TS; Martini CH; Tijl FGJ; Vuyk J; van Erkel AR; van der Velde CJH; Kapiteijn E; Vahrmeijer AL
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1196-1205. PubMed ID: 28451811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
    Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
    Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma.
    Chandrasekhar S; Perez M; Niaz Z; Ekram J; Lal N; Koly S; Cao B; Zager JS; Alomar M
    Cancer Control; 2024; 31():10732748241246898. PubMed ID: 38605434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience.
    Artzner C; Mossakowski O; Hefferman G; Grosse U; Hoffmann R; Forschner A; Eigentler T; Syha R; Grözinger G
    Cancer Imaging; 2019 May; 19(1):31. PubMed ID: 31146793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors.
    Kirstein MM; Marquardt S; Jedicke N; Marhenke S; Koppert W; Manns MP; Wacker F; Vogel A
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):2113-2121. PubMed ID: 28634727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery.
    Dewald CLA; Becker LS; Maschke SK; Meine TC; Alten TA; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
    Clin Exp Metastasis; 2020 Dec; 37(6):683-692. PubMed ID: 33034815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Isolated Hepatic Perfusion: Hemodynamic Monitoring and Goal-Directed Anesthetic Management: A Case Report.
    Martin-Delgado O; Rodriguez M; Lopez A; Reina MA; De Vicente E; Quijano Y; Echenagusia A; Martinez JA
    A A Case Rep; 2017 Jun; 8(11):300-303. PubMed ID: 28328586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies.
    Pingpank JF; Libutti SK; Chang R; Wood BJ; Neeman Z; Kam AW; Figg WD; Zhai S; Beresneva T; Seidel GD; Alexander HR
    J Clin Oncol; 2005 May; 23(15):3465-74. PubMed ID: 15908655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated hepatic perfusion for metastatic melanoma.
    Yamamoto M; Zager JS
    J Surg Oncol; 2014 Mar; 109(4):383-8. PubMed ID: 24166748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
    Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
    Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.
    Karydis I; Gangi A; Wheater MJ; Choi J; Wilson I; Thomas K; Pearce N; Takhar A; Gupta S; Hardman D; Sileno S; Stedman B; Zager JS; Ottensmeier C
    J Surg Oncol; 2018 May; 117(6):1170-1178. PubMed ID: 29284076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma.
    Schönfeld L; Hinrichs JB; Marquardt S; Voigtländer T; Dewald C; Koppert W; Manns MP; Wacker F; Vogel A; Kirstein MM
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):3003-3012. PubMed ID: 32564137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma.
    Deneve JL; Choi J; Gonzalez RJ; Conley AP; Stewart S; Han D; Werner P; Chaudhry TA; Zager JS
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1480-7. PubMed ID: 22699779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion.
    Rashid OM; Sloot S; Zager JS
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1355-64. PubMed ID: 25176398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.
    Uzgare RP; Sheets TP; Johnston DS
    Anticancer Res; 2013 May; 33(5):1989-2000. PubMed ID: 23645748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma.
    Varghese S; Xu H; Bartlett D; Hughes M; Pingpank JF; Beresnev T; Alexander HR
    Ann Surg Oncol; 2010 Jul; 17(7):1870-7. PubMed ID: 20221901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.